Member Info for Prion25

Hxul

Countries develop their hydrogen economies for decarbonisation using green hydrogen produced via renewable-powered electrolysis, emits no carbon when used—making it ideal for sectors where direct electrification is tough, such as

Steelmaking

Shipping and aviation

Heavy-duty transport

Chemical manufacturing

Not so stupid then as part of a clean energy strategy portfolio

Has Bosch forsaken Ceres for Sweden’s Powercell?

Https://www.hydrogeninsight.com/transport/bosch-acquires-rights-to-powercell-hydrogen-fuel-cell-technology-for-expansion-into-chinese-auto-market/2-1-1832961

Great news for ITM this morning and Bosch yet we still await

Charlotte’s Battle Against Glioblastoma on BBC this morning very sad worth checking out

ULTRARAM sounds like a futuristic AI innovation what will it mean to good old pounds shillings and pence and SP🤞

Thorn

Standard Dox is a first line therapy for STS as CC said it is used as a comparator for new drugs in treatment STS but many drugs failed to show ( an example below ) an improvement in OS when compared with standard dox and therefore investigations in the new drugs are discontinued Even though AVA6000 has the benefit of reduced toxicities CC made a shrewd move to trial Salivary Gland Cancer to show remarkable efficacy and safety data in this cohort " to turn heads " in the direction of the precision platform. I only wish Synairgen had followed a similar design in their trial . Their drug efficacy was no better than placebo because of improved SOC and dexamethasone That mistake cost me a fortune when the SP crashed but they have learnt lessons and are pursuing another trial with a specific cohort

https://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-00131-x

Labour's Golden age of clean energy is Nuclear. Hoping the waste heat can provide Ceres the most efficient production of green hydrogen opportunities

I am of a certain age and "a quick couple of bucks" is not going to happen anytime soon I will look at this has a long term investment for the family.But spare a thought for cancer patients lying in hospital beds who could have benefited from the ground breaking treatment will have to wait too Never could understand the regulatory pathways a "change of a molecule " in an approved drug to create a less toxic and safe drug with a brilliant proof of concept tech could be so oppressively prescriptive

“FAP-EXd (AVA6103) has advanced into IND-enabling work this year and we plan to initiate the Phase 1 trial in early 2026. In parallel, we are actively pursuing a number of commercial opportunities.”

Need clarification at 11 am meet a number of commercial opportunities being pursued is reassuring

Good riposte

BV

Wow they might be on it OBD working with Royal Marsden cancer care

I do not think it is us but similar tech unable to research on holiday

In today’s Daily Mail

Richard Hughes established Maggies cancer charity

Why read this BB when the recent RNS ‘s have been positive is all you need to know Opinions just like ass holes every one got one or is one

L

Had a reply from REDX IR

We appreciate your continued support and interest in Redx. On delisting, Redx committed to maintaining a matched bargain facility through JP Jenkins for a year to assist shareholders wishing to trade, which the company has done. There have been no buyers, however, through the platform during this period. As a private company, Redx is not obliged to maintain this indefinitely and accordingly has made a decision to discontinue the facility. The discontinuation of the facility does not impact your shares in Redx which you continue to hold. Please note that private company shares can still be traded via private transactions, either through Hargreaves & Lansdown (as your broker if they are able to do so) or yourself if you hold your holding directly.

I trust the above assists. For ongoing communications please refer to the news section of our website for updates.

Mr P. Thanks

Should have said will Bosch buy back more

Great news .Will Bosch buy back in ?

You would have thought Tempus AI and FAP expression data would have been as sufficient as a companion diagnostic in STC patient selection . Is my understanding incorrect ?

Fascinating Transformational